Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform recommendation. As of February 19, 2025, the average one-year price ...

With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford.

William Blair started coverage on shares of Structure Therapeutics (NASDAQ:GPCR – Free Report) in a research note published on Friday, Marketbeat Ratings reports. The brokerage issued an ...

Cell therapy developer CARGO Therapeutics (NASDAQ:CRGX) traded higher on Tuesday after William Blair launched its coverage with ... “We believe near-term initiatives to expand CAR-T access ...

William Blair sees room for margin expansion in fiscal 2027 as revenue growth accelerates, retention improves, and PLG initiatives gain traction. While macro sensitivity and competition remain ...

Kennedy highlighted that since William Blair initiated coverage on Nayax ... These recent developments reflect Nayax’s strategic initiatives to expand its market presence and improve its ...

On Monday, William Blair reaffirmed a Market Perform rating ... sequential sales growth throughout the year. The company's initiatives, if successful, may set Kenvue on a course to reach its ...